Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Assets (2016 - 2025)

Editas Medicine (EDIT) has disclosed Assets for 11 consecutive years, with $201.8 million as the latest value for Q3 2025.

  • Quarterly Assets fell 38.41% to $201.8 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $201.8 million through Sep 2025, down 38.41% year-over-year, with the annual reading at $341.6 million for FY2024, 31.57% down from the prior year.
  • Assets for Q3 2025 was $201.8 million at Editas Medicine, down from $210.6 million in the prior quarter.
  • The five-year high for Assets was $780.3 million in Q1 2021, with the low at $201.8 million in Q3 2025.
  • Average Assets over 5 years is $492.6 million, with a median of $504.6 million recorded in 2023.
  • The sharpest move saw Assets soared 67.18% in 2021, then crashed 45.28% in 2025.
  • Over 5 years, Assets stood at $677.5 million in 2021, then decreased by 24.08% to $514.3 million in 2022, then fell by 2.95% to $499.2 million in 2023, then tumbled by 31.57% to $341.6 million in 2024, then crashed by 40.94% to $201.8 million in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $201.8 million, $210.6 million, and $263.7 million for Q3 2025, Q2 2025, and Q1 2025 respectively.